9/18
06:43 am
apvo
Aptevo Therapeutics (NASDAQ:APVO) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
High
Report
Aptevo Therapeutics (NASDAQ:APVO) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
9/18
06:43 am
apvo
Aptevo Therapeutics (NASDAQ:APVO) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
High
Report
Aptevo Therapeutics (NASDAQ:APVO) was upgraded by analysts at Roth Capital to a "strong-buy" rating.